EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Organoids in breast cancer translational research: intersection of technologies

Qimin Xu, Sangsang Zhu, Meijun Wang, Yi Zhang, Zhen Wang, Jian Huang

Translational Breast Cancer Research · 2025-10 · 6 · 35-35

DOI: 10.21037/tbcr-24-22 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Breast Cancer Research, 2025-10. Verfasst von Qimin Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery (Surgical Oncology), Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer has a high incidence and high heterogeneity among women worldwide, but its lack of highly consistent in vitro research models has limited the translation of experimental results into clinical applications. The emergence of tumor organoids in the new era has aroused great interest among scientists. Organoids possess multi-omics characteristics highly preserved from parental tumors and offer advantages such as long-term and stable passaging and visualization in vitro. Thus, they have overcome multiple defects of two-dimensional (2D) cell cultures and patient-derived xenografts (PDXs). However, the lack of inter-organoid homogeneity, vascular-like fluid system and complex microenvironment has affected their wider applications, making it urgent to introduce new approaches for developing a more comprehensive functionality of this model. In recent years, the combination of tumor organoids with other innovative technologies has provided some relevantly important solutions and made it an optimal high-throughput and high-fidelity in vitro model. Here, we provide an overview of the development and optimization of breast cancer organoids, discuss how they have been integrated with several emerging technologies, and further summarize their applications in functional precision oncology. We believe that the intersection of new technologies has great potential in breast cancer translational research, which may finally provide new insights into organoid-guided breast cancer diagnosis and individualized treatment.

Schlagwörter

Stichwörter der Autor:innen

Breast canceremerging technologiesorganoids

Autor:innen und Institutionen

  • Department of Breast Surgery (Surgical Oncology), Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Hangzhou, China.
  • Cancer Centre, Zhejiang University, Hangzhou, China.
  • Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Zitieren

APA

Xu, Q., Zhu, S., Wang, M., Zhang, Y., Wang, Z., & Huang, J. (2025). Organoids in breast cancer translational research: intersection of technologies. Translational Breast Cancer Research, 6, 35-35. https://doi.org/10.21037/tbcr-24-22

Vancouver

Xu Q, Zhu S, Wang M, Zhang Y, Wang Z, Huang J. Organoids in breast cancer translational research: intersection of technologies. Translational Breast Cancer Research. 2025;6:35-35. doi:10.21037/tbcr-24-22

BibTeX
@article{Xu2025,
  author = {Xu, Qimin and Zhu, Sangsang and Wang, Meijun and Zhang, Yi and Wang, Zhen and Huang, Jian},
  title = {Organoids in breast cancer translational research: intersection of technologies},
  journal = {Translational Breast Cancer Research},
  year = {2025},
  volume = {6},
  pages = {35--35},
  doi = {10.21037/tbcr-24-22}
}
Kostenlos starten →